Genomic Valley Biotech Ltd vs Ptl Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 13, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 20.58 as of 13 Mar 11:45 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of PTL Enterprises Ltd changed from 3.7 on March 2021 to 13.7 on March 2025 . This represents a CAGR of 29.93% over 5 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of PTL Enterprises Ltd changed from ₹ 256.81 crore on March 2021 to ₹ 496.55 crore on March 2025 . This represents a CAGR of 14.10% over 5 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of PTL Enterprises Ltd for the Dec '25 is ₹ 16.17 crore as compare to the Sep '25 revenue of ₹ 21.59 crore. This represent the decline of -25.1% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of PTL Enterprises Ltd for the Dec '25 is ₹ 14.5 crore as compare to the Sep '25 ebitda of ₹ 20.28 crore. This represent the decline of -28.5% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of PTL Enterprises Ltd changed from ₹ 5.23 crore to ₹ 8.93 crore over 7 quarters. This represents a CAGR of 35.76% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of PTL Enterprises Ltd changed from 47.26 % on March 2021 to 63.83 % on March 2025 . This represents a CAGR of 6.20% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About PTL Enterprises Ltd

PTL Enterprises Limited, formerly known as Premier Tyres Limited was incorporated in 1959, which subsequently changed the name of the Company to 'PTL Enterprises Limited' effective on May 20, 2005.
The tyres manufacturing facility of PTL at Kalamassery, Kerala, is leased out to ApolloTyres Limited and all production is done by Apollo Tyres Limited. The Company was declared a sick unit by the Board for Industrial and Financial Reconstruction (BIFR) and under a rehabilitation scheme prescribed by the Board, PTL was taken over by Apollo Tyres in 1995.
This involved Apollo subscribing to Premier's additional equity of Rs 10 cr at par.
The authorised capital of the company has increased from Rs 4 cr to Rs 14 cr and its registered office shifted from Mumbai to Cochin. According to the BIFR order, Apollo will operate Premier's plant on an irrevocable lease of 8 years and pay a total lease rental amounting to Rs 45.

FAQs for the comparison of Genomic Valley Biotech Ltd and PTL Enterprises Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or PTL Enterprises Ltd?

Market cap of Genomic Valley Biotech Ltd is 7 Cr while Market cap of PTL Enterprises Ltd is 499 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and PTL Enterprises Ltd?

The stock performance of Genomic Valley Biotech Ltd and PTL Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and PTL Enterprises Ltd?

As of March 13, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹25.13. On the other hand, PTL Enterprises Ltd stock price is INR ₹37.76.

How do dividend payouts of Genomic Valley Biotech Ltd and PTL Enterprises Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and PTL Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.